As of Sep 02
| +0.06 / +3.33%|
The 2 analysts offering 12-month price forecasts for MEI Pharma Inc have a median target of 5.00, with a high estimate of 7.00 and a low estimate of 3.00. The median estimate represents a +168.82% increase from the last price of 1.86.
The current consensus among 4 polled investment analysts is to Hold stock in MEI Pharma Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.